CYTOKINETICS INC (CYTK)

US23282W6057 - Common Stock

48.87  +2.13 (+4.56%)

After market: 48.87 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
70.4M
26.16%
94.6M
34.38%
7.53M
-92.04%
6.109M
-18.87%
54.691M
795.25%
322.87M
490.35%
807.43M
150.08%
1.404B
73.89%
2.08B
48.15%
2.731B
31.30%
3.161B
15.75%
EBITDA
YoY % growth
-184.02M
-99.87%
-318.39M
-73.02%
-484.313M
-52.11%
-551.285M
-13.83%
-596.573M
-8.21%
-448.008M
24.90%
231.11M
151.59%
420.8M
82.08%
702.86M
67.03%
757.08M
7.71%
N/A
EBIT
YoY % growth
-186.3M
-98.40%
-324.2M
-74.02%
-496.205M
-53.06%
-556.315M
-12.11%
-611.449M
-9.91%
-441.363M
27.82%
-166.106M
62.37%
258.25M
255.47%
724.64M
180.60%
1.149B
58.56%
1.553B
35.16%
Operating Margin
-264.63%-342.71%-6,589.71%-9,106.49%-1,118.01%-136.70%-20.57%18.39%34.84%42.07%49.13%
EPS
YoY % growth
-2.83
-40.80%
-4.22
-49.12%
-5.45
-29.15%
-5.43
0.41%
-5.47
-0.71%
-3.96
27.63%
-1.00
74.82%
1.52
252.35%
4.44
192.61%
6.87
54.71%
9.38
36.58%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.32
4.70%
-1.30
1.99%
-1.34
-1.97%
-1.39
-2.29%
-1.29
2.07%
-1.12
13.93%
-1.06
20.59%
-0.90
35.48%
-0.65
49.31%
Revenue
Q2Q % growth
1.995M
19.32%
510K
-38.92%
1.785M
616.87%
3.647M
687.69%
17.051M
754.69%
31.253M
6,028.04%
46.879M
2,526.27%
70.319M
1,828.13%
108.63M
537.09%
EBITDA
Q2Q % growth
-153.924M
-33.24%
-151.072M
-21.93%
-154.703M
-23.33%
-161.578M
-20.89%
-155.162M
-0.80%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-152.185M
-19.44%
-156.592M
-24.05%
-158.093M
-21.45%
-163.576M
-16.18%
-152.917M
-0.48%
-154.299M
1.46%
-146.883M
7.09%
-132.92M
18.74%
-106.289M
30.49%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-1.36
-0.74%
-1.27-0.09-6.82%
Q2 2024
Q2Q % growth
-1.31
2.24%
-1.08-0.23-21.59%
Q1 2024
Q2Q % growth
-1.33
3.62%
-1.16-0.17-14.19%
Q4 2023
Q2Q % growth
-1.38
4.83%
-0.99-0.39-39.39%
Q3 2023
Q2Q % growth
-1.35
11.18%
-0.76-0.59-78.29%
Q2 2023
Q2Q % growth
-1.34
-482.61%
-1.17-0.17-14.64%
Q1 2023
Q2Q % growth
-1.38
-35.29%
-1.22-0.16-12.82%
Q4 2022
Q2Q % growth
-1.45
-302.78%
-1.23-0.22-17.89%
Q3 2022
Q2Q % growth
-1.52
-60.00%
-1.19-0.33-27.35%
Q2 2022
Q2Q % growth
-0.23
73.26%
-1.040.8177.91%
Q1 2022
Q2Q % growth
-1.02
-54.55%
-0.96-0.06-5.96%
Q4 2021
Q2Q % growth
-0.36
41.94%
-0.860.5057.99%
Q3 2021
Q2Q % growth
-0.95
-1,800.00%
-0.79-0.16-20.57%
Q2 2021
Q2Q % growth
-0.86
-26.47%
-0.67-0.19-27.75%
Q1 2021
Q2Q % growth
-0.66 -0.60-0.06-10.85%
Q4 2020
Q2Q % growth
-0.62
-19.23%
-0.31-0.31-101.77%
Q3 2020
Q2Q % growth
-0.05
90.00%
-0.340.2985.48%
Q2 2020
Q2Q % growth
-0.68
-21.43%
-0.58-0.10-17.25%
Q1 2020
Q2Q % growth
-0.66
-22.22%
-0.51-0.15-29.85%
Q4 2019
Q2Q % growth
-0.52
-8.33%
-0.45-0.07-15.86%
Q3 2019
Q2Q % growth
-0.50
-25.00%
-0.500.000.37%
Q2 2019
Q2Q % growth
-0.56
-9.80%
-0.51-0.05-10.69%
Q1 2019
Q2Q % growth
-0.54
3.57%
-0.48-0.06-12.64%
Q4 2018
Q2Q % growth
-0.48 -0.530.059.15%
Q3 2018
Q2Q % growth
-0.40 -0.520.1222.50%
Q2 2018
Q2Q % growth
-0.51 -0.520.011.57%
Q1 2018
Q2Q % growth
-0.56 -0.51-0.05-9.80%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
463K
22.49%
1.219M-756K-62.02%
Q2 2024
Q2Q % growth
249K
-71.28%
940.012K-691.012K-73.51%
Q1 2024
Q2Q % growth
835K
-81.90%
917.612K-82.612K-9.00%
Q4 2023
Q2Q % growth
1.672M
-14.69%
10.985M-9.313M-84.78%
Q3 2023
Q2Q % growth
378K
-85.00%
20.649M-20.271M-98.17%
Q2 2023
Q2Q % growth
867K
-99.03%
5.92M-5.053M-85.35%
Q1 2023
Q2Q % growth
4.613M
301.13%
2.131M2.482M116.47%
Q4 2022
Q2Q % growth
1.96M
-96.47%
7.241M-5.281M-72.93%
Q3 2022
Q2Q % growth
2.52M
-53.68%
3.017M-497K-16.47%
Q2 2022
Q2Q % growth
88.97M
3,032.75%
3.704M85.266M2,302.00%
Q1 2022
Q2Q % growth
1.15M
-82.44%
4.924M-3.774M-76.65%
Q4 2021
Q2Q % growth
55.6M
727.38%
6.321M49.279M779.61%
Q3 2021
Q2Q % growth
5.44M
-86.95%
6.465M-1.025M-15.85%
Q2 2021
Q2Q % growth
2.84M
-20.89%
5.559M-2.719M-48.91%
Q1 2021
Q2Q % growth
6.55M
71.02%
6.715M-165K-2.46%
Q4 2020
Q2Q % growth
6.72M
28.98%
8.729M-2.009M-23.02%
Q3 2020
Q2Q % growth
41.69M
587.95%
4.097M37.593M917.57%
Q2 2020
Q2Q % growth
3.59M
-49.72%
4.154M-564K-13.58%
Q1 2020
Q2Q % growth
3.83M
-54.73%
5.106M-1.276M-24.99%
Q4 2019
Q2Q % growth
5.21M
-44.46%
7.339M-2.129M-29.01%
Q3 2019
Q2Q % growth
6.06M
-43.05%
7.67M-1.61M-20.99%
Q2 2019
Q2Q % growth
7.14M
14.79%
7.13M10K0.14%
Q1 2019
Q2Q % growth
8.46M
60.53%
6.999M1.461M20.87%
Q4 2018
Q2Q % growth
9.38M 4.021M5.359M133.28%
Q3 2018
Q2Q % growth
10.64M 3.215M7.425M230.95%
Q2 2018
Q2Q % growth
6.22M 5.29M930K17.58%
Q1 2018
Q2Q % growth
5.27M 7.65M-2.38M-31.11%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-1.08% -16.96% -1.15% -2.64%
Revenue-2.83% 115.31% -6.76% -18.37%